RDHL News and Press, Redhill Biopharma Ltd. From 05/01/23

RedHill's RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting PR Newswire European Patent Office grants RHB-102 patent covering antiemetic extended-release solid dosage forms for the prevention of nausea and vomiting (CINV/RINV), providing protection o...

2023-04-28 07:30:34 ET RedHill press release ( NASDAQ: RDHL ): Q4 GAAP EPS of -$0.12. Revenue of $61.8M (-27.9% Y/Y). For further details see: RedHill GAAP EPS of -$0.12, revenue of $61.8M

RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights PR Newswire Having extinguished all debt and significantly reduced cost-base, RedHill is now ...

2023-04-11 07:17:29 ET Nasdaq notifies RedHill Biopharma ( NASDAQ: RDHL ) on regaining compliance with the minimum bid price requirement The company maintained a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days, which was achieved o...

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire TEL AVIV, Israel & RALEIGH, N.C. , April 11, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceuti...

RedHill Biopharma Announces Closing of $6 Million Registered Direct Offering PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , April 3, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical c...

2023-03-30 08:20:35 ET RedHill Biopharma ( NASDAQ: RDHL ) entered into a definitive agreement for the purchase and sale of 1.5M ADSs; each ADS represents 400 ordinary shares, series A warrants to purchase up to 1.5M ADSs and series B warrants to purchase up to 1.5M ADSs at a p...

RedHill Biopharma Announces $6 Million Registered Direct Offering PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , March 30, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, to...

RedHill Initiates First Community-Setting Warranty Program to Refund Talicia Non-Responders PR Newswire RedHill commits to reimburse out-of-pocket costs for Talicia patients that complete the full 14-day treatment course and whose infection is not eradicated based on post-...

2023-03-17 02:19:01 ET RedHill Biopharma ( NASDAQ: RDHL ) plans to change the ADS ratio to its non-traded ordinary shares, from one ADS representing ten ordinary shares to one ADS representing four hundred ordinary shares. For the company ...